This content is machine translated An update Cochrane analysis compares eleven substances in MS The aim of a recent meta-analysis by the Cochrane Collaboration was to compare eleven agents used in relapsing-remitting multiple sclerosis (RRMS) in terms of reduction in relapse rates, disability progression,…
